Cart is empty
English Nemecký Rakúsky Schweizer Nederlands Italiano Slovenský
FAQ            Contact
New registration | Login
10 x Packs Kamagra oral jelly 100mg (70 Jellies) 10 x Packs Kamagra oral jelly 100mg (70 Jellies)
  Kamagra Oral Jelly is a popular and effective treatment for ...
10 x packs Kamagra Gold 100mg (40 pills) 10 x packs Kamagra Gold 100mg (40 pills)
  Kamagra 100mg Generic Viagra™ Tablets are a very popular, successful ...
10 x Packs Kamagra effervescent 100mg (70 Pills) 10 x Packs Kamagra effervescent 100mg (70 Pills)
Kamagra Effervescent Generic Viagra Tablets are used in the treatment ...
Avaforce 100mg Avaforce 100mg
...
Kamagra 100mg Kamagra 100mg
  Kamagra 100mg Generic Viagra™ Tablets are a very popular, successful ...
Kamagra gold 100mg Kamagra gold 100mg
  Kamagra 100mg Generic Viagra™ Tablets are a very popular, successful ...
Cobra 120mg Cobra 120mg
Sildenafil Citrate 120mg Read all of this leaflet carefully before you ...
Kamagra oral jelly 100mg Kamagra oral jelly 100mg
  Kamagra Oral Jelly is a popular and effective treatment for ...
Kamagra effervescent 100mg Kamagra effervescent 100mg
Kamagra Effervescent Generic Viagra Tablets are used in the treatment ...
Sildaforce 100mg (Sextreme) Sildaforce 100mg (Sextreme)
Sildaforce 100mg Generic Viagra™ Tablets are a very popular, successful ...
Sildaforce 150mg Sildaforce 150mg
Sildaforce 150mg Generic Viagra™ Tablets are a very popular, successful and ...
Tadaforce 20mg Tadaforce 20mg
Tadaforce 20mg are a popular and successful treatment for erectile dysfunction. Containing ...
Sildenafil

Clinical safety of oral sildenafil citrate (VIAGRA (TM)) in the treatment of erectile dysfunction

Sildenafil citrate has been shown to be effective in a wide range of patients with erectile dysfunction and has been approved in the United States for this indication. The overall clinical safety of oral sildenafil, a potent inhibitor of phosphodiesterase type 5, in the treatment of erectile dysfunction was evaluated in more than 3700 patients (with a total of 1631 years of exposure worldwide). Safety and tolerability data were analysed from a series of double-blind, placebo-controlled studies and from 10 open-label extension studies of sildenafil in the treatment of erectile dysfunction. A total of 4274 patients (2722 sildenafil, 1552 placebo; age range 19-87 y) received double-blind treatment over a period of up to six months' duration, and 2199 received long-term, open-label sildenafil for up to 1 y.

The most commonly reported adverse events (all causes) were headache (16% sildenafil, 4% placebo), flushing (10% sildenafil, 1% placebo), and dyspepsia (7% sildenafil, 2% placebo) and they were predominantly transient and mild or moderate in nature. These adverse events reflect the pharmacology of sildenafil as a phosphodiesterase type 5 inhibitor. No cases of priapism were reported. The rate of discontinuation due to adverse events (all causes) was comparable for patients treated with sildenafil (2.5%) and placebo (2.3%). In open-label extension studies, 90% of patients completed long-term sildenafil treatment, with only 2% withdrawing due to adverse events. Sildenafil is a well-tolerated oral treatment for erectile dysfunction.

(PDF) Clinical safety of oral sildenafil citrate (VIAGRA (TM)) in the treatment of erectile dysfunction. Available from: https://www.researchgate.net/publication/13636709_Clinical_safety_of_oral_sildenafil_citrate_VIAGRA_TM_in_the_treatment_of_erectile_dysfunction

Author: A Morales, C Gingell, M Collins, PA Wicker, IH Osterloh